Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
greg yap
health tech
joshua brumm
kaleido biosciences
life sciences
menlo ventures
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
venture capital
vertex pharmaceuticals
What
early
3
×
long
3
×
data
medical
according
act
acute
ago
association
balancing
bed
biology
biotechs
british
called
ceo
charge
company
compared
considering
decided
discharge
diseases
dives
doccla
driven
drug
dyne
enable
entrepreneur
expected
experimental
eyes
firm
firms
forced
genetic
greg
having
health
Language
unset
Current search:
long
×
early
×
@tech.eu
1 year ago
Virtual ward company Doccla raises £15 million to enable early discharge of patients
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
6 years ago
Menlo Ventures dives into data-driven health care investing with its newest partner
